{"id":395639,"date":"2025-04-09T01:05:00","date_gmt":"2025-04-08T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=395639"},"modified":"2025-04-09T08:05:11","modified_gmt":"2025-04-09T06:05:11","slug":"nouvelles-donnees-detude-sur-linhibition-de-lil-23","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/nouvelles-donnees-detude-sur-linhibition-de-lil-23\/","title":{"rendered":"Nouvelles donn\u00e9es d&#8217;\u00e9tude sur l&#8217;inhibition de l&#8217;IL-23"},"content":{"rendered":"\n<p><strong>Le psoriasis se manifeste dans les r\u00e9gions palmoplantaires et intertrigineuses ou sur les ongles, ce qui repr\u00e9sente souvent un d\u00e9fi th\u00e9rapeutique. Plusieurs analyses r\u00e9centes sur les effets des anticorps anti-IL-23p19 actuellement autoris\u00e9s dans le psoriasis se sont concentr\u00e9es sur les populations de patients atteints de ces r\u00e9gions du corps difficiles \u00e0 traiter. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fnouvelles-donnees-detude-sur-linhibition-de-lil-23%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Le psoriasis se manifeste dans les r\u00e9gions palmoplantaires et intertrigineuses ou sur les ongles, ce qui repr\u00e9sente souvent un d\u00e9fi th\u00e9rapeutique. Plusieurs analyses r\u00e9centes sur les effets des anticorps anti-IL-23p19&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fnouvelles-donnees-detude-sur-linhibition-de-lil-23%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":395641,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Psoriasis dans les localisations difficiles \u00e0 traiter  ","footnotes":""},"category":[11549,11362,11527,11531,11428,11505],"tags":[81406,9494,81409,81463,81466,67786,81462,81407,384,12375,9361,67536],"powerkit_post_featured":[],"class_list":["post-395639","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-dermatologie-et-venerologie","category-etudes","category-formation-continue","category-infectiologie","category-rhumatologie","tag-cassiopee","tag-guselkumab","tag-immprint","tag-inhibition-de-lil-23","tag-intertrigineux","tag-localisations","tag-palmoplantaires","tag-positive","tag-psoriasis","tag-psoriasis-des-ongles","tag-risankizumab","tag-tildrakizumab","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-22 06:55:40","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":395732,"slug":"nuovi-dati-di-studio-sullinibizione-dellil-23","post_title":"Nuovi dati di studio sull'inibizione dell'IL-23","href":"https:\/\/medizinonline.com\/it\/nuovi-dati-di-studio-sullinibizione-dellil-23\/"},"pt_PT":{"locale":"pt_PT","id":395645,"slug":"novos-dados-de-estudo-sobre-a-inibicao-da-il-23","post_title":"Novos dados de estudo sobre a inibi\u00e7\u00e3o da IL-23","href":"https:\/\/medizinonline.com\/pt-pt\/novos-dados-de-estudo-sobre-a-inibicao-da-il-23\/"},"es_ES":{"locale":"es_ES","id":395729,"slug":"nuevos-datos-de-estudios-sobre-la-inhibicion-de-la-il-23","post_title":"Nuevos datos de estudios sobre la inhibici\u00f3n de la IL-23","href":"https:\/\/medizinonline.com\/es\/nuevos-datos-de-estudios-sobre-la-inhibicion-de-la-il-23\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/395639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=395639"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/395639\/revisions"}],"predecessor-version":[{"id":395642,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/395639\/revisions\/395642"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/395641"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=395639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=395639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=395639"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=395639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}